E-resources
Peer reviewed
Open access
-
Mehdipour, Parinaz; Rajasekhar, Megha; Dini, Saber; Zaloumis, Sophie; Abreha, Tesfay; Adam, Ishag; Awab, Ghulam Rahim; Baird, J Kevin; Brasil, Larissa W; Chu, Cindy S; Cui, Liwang; Daher, André; do Socorro M Gomes, Margarete; Gonzalez-Ceron, Lilia; Hwang, Jimee; Karunajeewa, Harin; Lacerda, Marcus V G; Ladeia-Andrade, Simone; Leslie, Toby; Ley, Benedikt; Lidia, Kartini; Llanos-Cuentas, Alejandro; Longley, Rhea J; Monteiro, Wuelton Marcelo; Pereira, Dhelio B; Rijal, Komal Raj; Saravu, Kavitha; Sutanto, Inge; Taylor, Walter R J; Thanh, Pham Vinh; Thriemer, Kamala; Vieira, José Luiz F; White, Nicholas J; Zuluaga-Idarraga, Lina M; Guerin, Philippe J; Price, Ric N; Simpson, Julie A; Commons, Robert J
Malaria journal, 10/2023, Volume: 22, Issue: 1Journal Article
Imperfect adherence is a major barrier to effective primaquine radical cure of Plasmodium vivax. This study investigated the effect of reduced adherence on the risk of P. vivax recurrence. Efficacy studies of patients with uncomplicated P. vivax malaria, including a treatment arm with daily primaquine, published between January 1999 and March 2020 were identified. Individual patient data from eligible studies were pooled using standardized methodology. Adherence to primaquine was inferred from i) the percentage of supervised doses and ii) the total mg/kg dose received compared to the target total mg/kg dose per protocol. The effect of adherence to primaquine on the incidence of P. vivax recurrence between days 7 and 90 was investigated by Cox regression analysis. Of 82 eligible studies, 32 were available including 6917 patients from 18 countries. For adherence assessed by percentage of supervised primaquine, 2790 patients (40.3%) had poor adherence (≤ 50%) and 4127 (59.7%) had complete adherence. The risk of recurrence by day 90 was 14.0% 95% confidence interval: 12.1-16.1 in patients with poor adherence compared to 5.8% 5.0-6.7 following full adherence; p = 0.014. After controlling for age, sex, baseline parasitaemia, and total primaquine dose per protocol, the rate of the first recurrence was higher following poor adherence compared to patients with full adherence (adjusted hazard ratio (AHR) = 2.3 1.8-2.9). When adherence was quantified by total mg/kg dose received among 3706 patients, 347 (9.4%) had poor adherence, 88 (2.4%) had moderate adherence, and 3271 (88.2%) had complete adherence to treatment. The risks of recurrence by day 90 were 8.2% 4.3-15.2 in patients with poor adherence and 4.9% 4.1-5.8 in patients with full adherence; p < 0.001. Reduced adherence, including less supervision, increases the risk of vivax recurrence.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.